Five of the eight companies acquired by Exact Sciences in the past three years are helping the Madison-based maker of the Cologuard stool-based colon cancer screening test work on its next goal: cancer blood tests, including one to detect more than a dozen types of cancer from one blood draw in people with few or no symptoms.
Conroy
People are also reading…
Burkard
Research associate Nick Goetz is among more than 450 scientists working on research into liquid biopsies at Exact.
Exact Sciences' corporate headquarters opened in 2020 at University Research Park, one of three Madison-area campuses for the company, which makes Cologuard, the stool-based colon cancer screening test.
Pfizer says new data suggests a third dose of its COVID vaccine can strongly increase protection against the delta variant.
Robotic equipment allows multiple samples to be processed quickly at Madison-based Exact Sciences, the maker of Cologuard, the stool-based colon cancer screening test.
To detect DNA fragments from tumors in blood, labs need to amplify DNA from samples. Research associate Breanna Richard prepares samples for amplification tests at Exact Sciences.
Murtaza
Hong
Lang
Minter
PHOTOS: Beloit company gears up to manufacture key isotope for nuclear medicine
Northstar Accelerators
Investor Diane Hendricks peers through a portal that will be used to place material in an electron particle accelerator at NorthStar Medical Radioisotopes in Beloit.
Northstar Accelerators
Workers move one of two electron particle beam accelerators into a factory at NorthStar Medical Radioisotopes in Beloit, where they will be used to make material used in medical procedures.
Northstar Accelerators 09-04202021152546
Workers prepare to install one of two 24-ton particle accelerators manufactured in Belgium for NorthStar Medical Radioisotopes in Beloit.
Northstar Accelerators 06-04202021152546
Mechanical arms used in the processing of MO-99. The radioactive isotope, to be manufactured in Beloit, is used in about 40,000 medical procedures each day in the United States.
Northstar Accelerators 04-04202021152546
Steve Merrick, president of NorthStar Medical Radioisotopes, guides visitors on a tour of the company’s Beloit facility, which will be used to make molybdenum-99, a radioactive isotope used in about 40,000 U.S. medical procedures each day.
Northstar Accelerators
Workers prepare to move one of two electron beam accelerators at NorthStar Medical Radioisotopes in Beloit as company CEO Steve Merrick delivers remarks in which he called the delivery "a major milestone for nuclear medicine."
Northstar Accelerators 07-04202021152546
Signs outside a quality control facility at NorthStar Medical Radioisotopes caution workers to a radioactivity hazard at the company in Beloit.
Northstar Accelerators 08-04202021152546
Delivery vessels used to contain the radioactive isotope MO-99 at NorthStar Medical Radioisotopes in Beloit. NorthStar is currently the only domestic producer of Mo-99, which has a shelf life of only 66 hours.
Northstar Accelerators 05-04202021152546
Iron doors and thick brick walls designed to contain radioactive particles will house electron beam accelerators used to manufacture the isotope MO-99 at NorthStar Medical Radioisotopes in Beloit.
102818-wsj-biz-northstar8
In this demonstration of how NorthStar Medical Radioisotopes' system will work, a pharmacist will prep an empty vial that will be placed inside a lead shield and inserted in NorthStar's RadioGenix system to collect technetium-99m, a crucial element in popular medical scans.
102818-wsj-biz-northstar7
NorthStar Medical Radioisotopes' source vessel.
NorthStar Medical Radioisotopes
NorthStar Medical Radioisotopes in Beloit announced last week that it had been awarded a $30 million cooperative agreement by the U.S. Department of Energy's National Nuclear Security Administration.
102818-wsj-news-northstar2
NorthStar Medical Radioisotopes' RadioGenix system, assembled in Beloit, works "like a Keurig coffeemaker," CEO Stephen Merrick says, except it makes a much-needed medical isotope instead of a morning beverage.
102818-wsj-news-northstar4
NorthStar Medical Technologies in Beloit.
04NorthStar0165AJA-02232018114351
Stephen Merrick, president and COO, gives a tour of NorthStar Medical Radioisotopes in Beloit, Wis., Wednesday, Feb. 21, 2018. AMBER ARNOLD, STATE JOURNAL
Northstar
A vial of molybdenum-98 will be transformed into a key radioisotope needed for common health screening tests through a system developed by NorthStar Medical Technologies, of Beloit.
102818-wsj-news-northstar6
RadioGenix systems wait to be shipped at NorthStar Medical Radioisotopes in Beloit.
Accelerator
Workers prepare to move two electron particle beam accelerators into a factory at NorthStar Medical Radioisotopes in Beloit.
Burkard
